How Well Does Disease-Modifying Therapy Work for Older Adults with MS?
Drug Topics
JULY 6, 2023
Researchers concluded that older patients with stable MS can stop taking disease-modifying therapy because risk of relapse is so small.
Sat.Jul 01, 2023 - Fri.Jul 07, 2023
247 
Bernie Sanders proposes price caps on drugs developed with federal funds
Fierce Pharma
JULY 6, 2023
After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
CMS proposes $375M cut to home health Medicare payments in 2024
Fierce Healthcare
JULY 4, 2023
The Biden administration issued a proposal Friday to cut reimbursements to home health providers by 2.2% next year, or an estimated $375 million less than 2023 payment levels. | The Biden administration issued a proposal Friday to cut reimbursements to home health providers by 2.2% next year, or an estimated $375 million less than 2023 payment levels.
Using Artificial Intelligence, Machine Learning to Aid in Skin Cancer Diagnoses
Drug Topics
JULY 5, 2023
How does AI help reduce the burden on specialist dermatology services and help simplify the screening process?
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
VA, Stanford Medicine unveil plans to develop new comprehensive cancer center in Palo Alto
Fierce Healthcare
JULY 6, 2023
Stanford Medicine and the Department of Veterans Affairs (VA) unveiled plans Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and rese | Stanford Medicine and the VA unveiled plans on Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and research center to the VA Palo Alto campus.
Health Equity in Pharma: Communities Most Impacted by Racial Bias
PharmExec
JULY 5, 2023
Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Eli Lilly’s retatrutide sets new record for weight loss in obesity space
Pharmaceutical Technology
JULY 3, 2023
Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.
Johnson & Johnson unloads eye drops line to acquisitive Bausch + Lomb as Brent Saunders' deal streak rolls on
Fierce Pharma
JULY 6, 2023
During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure. | During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure.
The Connection Between OUD and Contraceptive Use
Drug Topics
JULY 7, 2023
A recent study shows decreased use of multiple types of contraception among patients struggling with OUD.
Following FDA’s full approval of Leqembi, here’s what else is in the Alzheimer’s pipeline
PharmaVoice
JULY 7, 2023
Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Study Finds Comorbidities, Pre-Existing Disease Have Significant Impact On COVID-19 Outcomes
Pharmacy Times
JULY 3, 2023
The study also found significant evidence of outcomes disparities between minority populations and White populations.
Digital health tech: a solution to substance use disorders?
Pharmaceutical Technology
JULY 4, 2023
Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.
Could a Second Dose of Novavax be a Game Changer for Adolescent COVID-19 Vaccination?
Drug Topics
JULY 7, 2023
Heterologous vaccination—or mixing different vaccines—was safe and effective with Novavax and provided enhanced protection against the Omicron variant, a new study found.
Pharma’s strike-from-all-sides attack on the IRA could be decided by the Supreme Court
PharmaVoice
JULY 6, 2023
New lawsuits challenging the Inflation Reduction Act’s price negotiation program hit the government with multiple Constitution-based challenges.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Parents Show Willingness to Participate in Mental Health Screenings for Children in Primary Care Settings
Pharmacy Times
JULY 6, 2023
The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.
Most ambulances ‘run hot’ with lights and sirens blaring. But that’s starting to change
STAT
JULY 7, 2023
Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio
Alzheimer Drug Lecanemab Gets Full FDA Approval
Drug Topics
JULY 7, 2023
The approval was based on a confirmatory trial that found the therapy slowed disease progression compared with placebo.
Women’s healthcare investments are hot. So where are the new menopause drugs?
PharmaVoice
JULY 5, 2023
NK3 receptor antagonists offer a new option, but experts say more are needed.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Potential Risk of Chronic Kidney Disease in Long Term Use of Acid Reducing Medications
Pharmacy Times
JULY 5, 2023
Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.
Novo Nordisk brings new round of lawsuits against compounded versions of Ozempic and Wegovy
Fierce Pharma
JULY 7, 2023
As demand skyrockets for GLP-1 drugs that can trigger significant weight loss, unauthorized versions of the treatments have started to fill pharmacies. | In late May, the FDA warned of illegal knockoffs of Novo Nordisk’s Ozempic and Wegovy. And now, the Danish company has filed its second wave of lawsuits against pharmacies in the U.S. that are producing the copycats.
Certain Antidepressants May Increase Lung Cancer Risk, Meta-Analysis Shows
Drug Topics
JULY 6, 2023
Other research has suggested that SNRIs can lead to DNA damage, which the investigators said may be the avenue by which the drugs affect lung cancer risk.
A BMS exec’s journey around the world in 90 days
PharmaVoice
JULY 5, 2023
As BMS grapples with upcoming patent cliffs, Emma Charles, the new SVP of intercontinental markets, is focused on expanding its footprint.
Digital health app users report increased bipolar depression correlated with worsening air quality
Fierce Healthcare
JULY 7, 2023
Air pollution shown to increase depression symptoms in individuals with bipolar disorder, a new study published by Cambridge University Press found.
Teva weighs sale of $2B API business as CEO Richard Francis embarks on 'Pivot to Growth' strategy: reports
Fierce Pharma
JULY 6, 2023
Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga have reported.
RxPreferred to Offer Yusimry Through Mark Cuban's Online Pharmacy
Drug Topics
JULY 6, 2023
The Humira biosimilar is a tumor necrosis factor (TNF) blocker and was approved by the FDA in 2021.
The stories you’ve read the most in 2023 (so far)
PharmaVoice
JULY 3, 2023
From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.
How a Rebirth Toward Preventing Inflammation Will Positively Impact Age-Related Diseases, Extend Longevity
Pharmacy Times
JULY 7, 2023
Diagnostic technologies are advancing quickly, which may lead to therapeutics for age-related diseases to safely reduce chronic low-grade inflammation generated by the immune system.
Psychedelics and mental health: The time is now?
pharmaphorum
JULY 4, 2023
Psychedelics and mental health: The time is now? Nicole.
Five Adalimumab Biosimilars Now Available in US Market
Drug Topics
JULY 5, 2023
These medications join adalimumab-atto, which launched on January 31.
What the end of affirmative action means to a fourth-year medical student
STAT
JULY 3, 2023
When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.
Expert: Newly Approved Alzheimer Disease Drug is a "First Step"
Pharmacy Times
JULY 7, 2023
Expert Nikhil Palekar, MD, said that although the treatment is far from a cure, it is a vital first step toward other treatments for Alzheimer Disease.
HITLAB summit warns that digital health for all will need careful investment
Fierce Healthcare
JULY 5, 2023
“Digital health will cease to exist,” read large on the screen behind Merck Global Health Initiative Fund President Bill Taranto at the second annual HITLAB Innovators Summit in New York City. | Columbia University hosted the second annual HITLAB Innovators Summit in New York City where industry insiders trumpeted the potential for digital health interventions while warning of the dangers of unchecked tech implementation.
Cyltezo Biosimilar Now Available in United States
Drug Topics
JULY 5, 2023
Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Let's personalize your content